Persistent Elevation of Thyroglobulin in Patient Treated for Differentiated Thyroid Cancer: A Ten-Year Review.

Sarah Khan, Roopashree Prabhushankar, Emily Leary, Uzma Z Khan

Open access · greenAbstract readReview

In one paragraph

Review in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 76% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Sarah KhanSarah Khan is at the University of Missouri School of Medicine.

Roopashree PrabhushankarRoopashree Prabhushankar, MD, is at Desert Kidney Associates, Endocrinology, Mesa, Arizona.

Emily LearyEmily Leary, PhD, is at the University of Missouri School of Medicine.

Uzma Z KhanUzma Z. Khan, MD, is at the University of Missouri School of Medicine, Department of Internal Medicine.

University of Missouri · USKidney Associates · USLear (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differentiated Thyroid Cancer (DTC) is increasing in prevalence due to better diagnostic tools and excellent long-term survival. This study is to understand the outcome of twenty-six patients with DTC over a period of 10 years after the initial treatment with surgery and radioiodine therapy. Our study analysis showed no deaths, and indicated that older men were more likely to have persistent disease. Further studies are needed to focus on cost effective long-term management of DTC.

Indexed as

AdultAgedCost-Benefit AnalysisDisease-Free SurvivalFemaleHumansIodine RadioisotopesMaleMiddle AgedMissouriNon-Randomized Controlled Trials as TopicPrevalenceRetrospective StudiesThyroglobulinThyroidectomyThyroid NeoplasmsIodine RadioisotopesThyroglobulin

Identifiers

PMID30228641

PMCPMC6140183

OpenAlexW2996889620

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.